BMF antibody (AA 2-14)
Quick Overview for BMF antibody (AA 2-14) (ABIN1732353)
Target
See all BMF AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 2-14
-
Specificity
- Reacts with the N-terminus part of human Bmf.
-
Purification
- Purified
-
Immunogen
- Peptide corresponding to aa 2-14 of human Bmf (accession no. NP_277038).
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
WB (2 μg/mL) ICC (10 μg/mL) -
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS, pH 7.4
-
Handling Advice
- Dilute in PBS or medium that is identical to that used in the assay system.
-
Storage
- -20 °C
-
Storage Comment
- Stable for at least one year at -20°C. Avoid multiple freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- BMF (Bcl2 Modifying Factor (BMF))
-
Alternative Name
- Bmf
-
Background
-
In healthy cells, Bmf associates with the dynein light chain 2 component of the myosin V motors and is sequestered by the cell's actin cytoskeleton. Disruption of the actin cytoskeleton, either by depolymerization of actin filaments or by detachment of cells from the extracellular matrix, triggers release and activation of Bmf, initiating the downstream apoptotic program. Bmf is constitutively expressed in many tissues.
Bcl-2-modifying factor Bcl 2-modifying factor Gene name: BMF -
Gene ID
- 90427
-
UniProt
- Q96LC9
Target
-